AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Funding Status:
N/A
Industry:
Vaccine/Drug
Technology:
COVID
Number Of Exists:
N/A
Headquarters:
Denmark
Investor Type:
N/A
Employee Number:
N/A
Investment Stage:
N/A
Founded Date:
N/A